Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.
Adult
Aged
Antibodies, Viral
/ blood
Blood Donors
/ statistics & numerical data
COVID-19
/ blood
Canada
/ epidemiology
Coronavirus Nucleocapsid Proteins
/ analysis
Cross-Sectional Studies
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Middle Aged
SARS-CoV-2
/ genetics
Seroepidemiologic Studies
Spike Glycoprotein, Coronavirus
/ analysis
Young Adult
IgG
SARS-CoV-2 antibody
latent class analysis
nucleocapsid
receptor binding domain
spike
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
23 02 2022
23 02 2022
Historique:
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
5
3
2022
Statut:
ppublish
Résumé
We have previously used composite reference standards and latent class analysis (LCA) to evaluate the performance of laboratory assays in the presence of tarnished gold standards. Here, we apply these techniques to repeated, cross-sectional study of Canadian blood donors, whose sera underwent parallel testing with four separate SARS-CoV-2 antibody assays. We designed a repeated cross-sectional design with random cross-sectional sampling of all available retention samples (
Identifiants
pubmed: 35196819
doi: 10.1128/spectrum.02563-21
pmc: PMC8865569
doi:
Substances chimiques
Antibodies, Viral
0
Coronavirus Nucleocapsid Proteins
0
Spike Glycoprotein, Coronavirus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0256321Subventions
Organisme : Abbott | Abbott Diagnostics
ID : Partial kit cost
Organisme : Alberta Innovates
ID : G2020000360Drews
Organisme : Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
ID : VR2-172723
Références
Ann Intern Med. 2021 Oct;174(10):1430-1438
pubmed: 34399059
PLoS One. 2021 Sep 23;16(9):e0257743
pubmed: 34555095
BMC Med. 2021 Oct 14;19(1):270
pubmed: 34649585
Prev Med Rep. 2021 Dec;24:101518
pubmed: 34458081
BMC Infect Dis. 2021 May 27;21(1):494
pubmed: 34044758
Transfusion. 2022 Jan;62(1):37-43
pubmed: 34662434
Transfusion. 2021 May;61(5):1440-1446
pubmed: 33734448
J Transl Med. 2009 Mar 26;7:23
pubmed: 19323808
Transfusion. 2021 Mar;61(3):862-872
pubmed: 33527398
Epidemiology. 2021 Jul 1;32(4):518-524
pubmed: 33935138
Vaccines (Basel). 2021 Sep 28;9(10):
pubmed: 34696200
Nat Commun. 2022 May 4;13(1):2451
pubmed: 35508478
Diagn Microbiol Infect Dis. 2021 Nov;101(3):115412
pubmed: 34425450
Microbiol Spectr. 2022 Feb 23;10(1):e0226221
pubmed: 35171006
Clin Transl Immunology. 2022 Mar 23;11(3):e1380
pubmed: 35356067
CMAJ. 2021 Oct 25;193(42):E1619-E1625
pubmed: 34610919
Trends Immunol. 2020 Oct;41(10):849-851
pubmed: 32680648
JCI Insight. 2020 Oct 2;5(19):
pubmed: 32870820
J Assoc Med Microbiol Infect Dis Can. 2021 Mar 25;6(2):73-78
pubmed: 36341029
JAMA. 2021 Oct 12;326(14):1400-1409
pubmed: 34473201